Sugi Predict

Sugi Predict / Compounds / SCHEMBL4570145

SCHEMBL4570145

SCHEMBL4570145

CC(C)OC(=O)Nc1ccc(N2CCC[C@]3(CCN([C@H]4CC[C@H](O)CC4)C3=O)C2)nc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 4/20 0.45
▸ DDB1 Q16531 1/20 0.38
▸ PDE7A Q13946 2/20 0.37
▸ DGAT1 O75907 2/20 0.36
▸ BTK Q06187 1/20 0.36
▸ TRPV1 Q8NER1 2/20 0.35
▸ DYRK1A Q13627 4/20 0.35
▸ CLK2 P49760 2/20 0.35
▸ GSK3B P49841 2/20 0.35
▸ KCNQ3 O43525 1/20 0.35
▸ KCNQ2 O43526 1/20 0.35
▸ FASN P49327 2/20 0.34
▸ CLK3 P49761 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ PIK3CA P42336 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17082086 1.00 CRBN (0.45) CRBNDDB1PDE7ADGAT1BTK
SCHEMBL4570062 0.92 CRBN (0.42) CRBNDDB1PDE7ADGAT1KCNQ3
SCHEMBL17082019 0.92 CRBN (0.42) CRBNDDB1PDE7ADGAT1KCNQ3
SCHEMBL17082114 0.91 CRBN (0.48) CRBNDDB1PDE7ATRPV1DYRK1A
SCHEMBL4570142 0.91 CRBN (0.48) CRBNDDB1PDE7ATRPV1DYRK1A
SCHEMBL17082122 0.89 CRBN (0.43) CRBNDDB1PDE7ADGAT1TRPV1
SCHEMBL4570141 0.89 CRBN (0.43) CRBNDDB1PDE7ADGAT1TRPV1
SCHEMBL2699052 0.89 CRBN (0.47) CRBNDDB1PDE7ATRPV1KCNQ3
SCHEMBL550214 0.89 CRBN (0.47) CRBNDDB1PDE7ATRPV1KCNQ3
SCHEMBL2699057 0.89 CRBN (0.47) CRBNDDB1PDE7ATRPV1KCNQ3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120122858-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2012-05-17 — — US disclosed
US-20120122858-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2012-05-17 — — US disclosed
US-8110581-B2 Lactam compounds and their use as pharmaceuticals INCYTE CORPORATION (US) 2012-02-07 — — US disclosed
US-8110581-B2 Lactam compounds and their use as pharmaceuticals INCYTE CORPORATION (US) 2012-02-07 — — US disclosed
US-20090291946-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2009-11-26 — — US disclosed
US-20090291946-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2009-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291946-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS HSD11B1, HSD11B2, HSD17B1 CRBN 2898/4885DDB1 3426/4885PDE7A 251/4885
US-20120122858-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS HSD11B1, HSD11B2, HSD17B1 CRBN 2898/4885DDB1 3426/4885PDE7A 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.